J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 576, Number 2, 585-594, October 15, 2006 DOI: 10.1113/jphysiol.2006.115998
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
576/2/585    most recent
jphysiol.2006.115998v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Queen, L. R.
Right arrow Articles by Ferro, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Queen, L. R.
Right arrow Articles by Ferro, A.
Related Collections
Right arrow Cardiovascular

CARDIOVASCULAR

Mechanisms underlying ß2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells

Lindsay R. Queen1, Yong Ji1, Biao Xu2, Lora Young1, Kang Yao3, Amanda W. Wyatt1, David J. Rowlands1, Richard C. M. Siow1, Giovanni E. Mann1 and Albert Ferro1

1 Cardiovascular Division, King's College London, London, UK
2 Cardiovascular Department, Affiliated Gulou Hospital, Medical School of Nanjing University, Nanjing, China
3 Department of Cardiology, Zhongda Hospital of Southeast University, Nanjing, China

Endothelial ß2-adrenoceptor (ß2AR) stimulation increases nitric oxide (NO) generation, but the underlying cellular mechanisms are unclear. We examined the role of L-arginine transport and of phosphorylation of NO synthase 3 (NOS-3) in ß2AR-mediated NO biosynthesis by human umbilical vein endothelial cells (HUVEC). To this end, we assessed L-arginine uptake, NOS activity (from L-arginine to L-citrulline conversion), membrane potential (using [3H]tetraphenylphosphonium), as well as serine phosphorylation of NOS-3 (by Western blotting and mass spectrometry), in HUVEC treated with ßAR agonists or cyclic AMP-elevating agents. ß2AR stimulation increased L-arginine transport, as did cyclic AMP elevation with either forskolin or dibutyryl cyclic AMP, and this increase was inhibitable by N-ethylmaleimide. Blockade of L-arginine uptake by L-lysine inhibited NOS activity and, conversely, blockade of NOS using N{omega}-nitro-L-arginine methyl ester (L-NAME) inhibited L-arginine transport. ß2AR stimulation also caused a membrane hyperpolarization inhibitable by L-NAME, suggesting that the increase in L-arginine uptake occurred in response to NO-mediated hyperpolarization. ß2AR activation also increased NOS activity and phosphorylation of NOS-3 on serine-1177, and these increases were attenuated by inhibition of protein kinase A (PKA), phosphatidylinositol 3-kinase (PI3K) or Akt, and abolished by coinhibition of PKA and Akt. These findings suggest that ß2AR-mediated NOS-3 activation in HUVEC is mediated through phosphorylation of NOS-3 on serine-1177 through both the PKA and the PI3K/Akt systems, and is sustained by an increase in L-arginine uptake resulting from NO-mediated membrane hyperpolarization.

(Received 26 June 2006; accepted after revision 26 July 2006; first published online 27 July 2006)
Corresponding author A. Ferro: 2.38A, New Hunts Hose, King's College London, Guy's Hospital Campus, London Bridge, London SE1 1UL, UK. Email: albert.ferro{at}kcl.ac.uk




This article has been cited by other articles:


Home page
EndocrinologyHome page
E. Grossini, C. Molinari, D. A. S. G. Mary, F. Uberti, P. P. Caimmi, N. Surico, and G. Vacca
Intracoronary Genistein Acutely Increases Coronary Blood Flow in Anesthetized Pigs through {beta}-Adrenergic Mediated Nitric Oxide Release and Estrogenic Receptors
Endocrinology, May 1, 2008; 149(5): 2678 - 2687.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Leblais, E. Delannoy, F. Fresquet, H. Begueret, N. Bellance, S. Banquet, C. Allieres, L. Leroux, C. Desgranges, A. Gadeau, et al.
{beta}-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent {beta}2 component in pulmonary hypertension
Cardiovasc Res, January 1, 2008; 77(1): 202 - 210.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Gkaliagkousi, J. Ritter, and A. Ferro
Platelet-Derived Nitric Oxide Signaling and Regulation
Circ. Res., September 28, 2007; 101(7): 654 - 662.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Molinari, E. Grossini, D. A. S. G. Mary, F. Uberti, E. Ghigo, F. Ribichini, N. Surico, and G. Vacca
Prolactin Induces Regional Vasoconstriction through the {beta}2-Adrenergic and Nitric Oxide Mechanisms
Endocrinology, August 1, 2007; 148(8): 4080 - 4090.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. E. Mann, D. J. Rowlands, F. Y.L. Li, P. de Winter, and R. C.M. Siow
Activation of endothelial nitric oxide synthase by dietary isoflavones: Role of NO in Nrf2-mediated antioxidant gene expression
Cardiovasc Res, July 15, 2007; 75(2): 261 - 274.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 The Physiological Society.